Sensex
Sensex and Nifty close lower in historic Muhurat trading session loss
Indian stock markets recorded a historic downturn during the annual Diwali Muhurat Trading session, breaking a nine-year winning streak for the benchmark indices.
Sensex drops 252 points as rising crude oil prices and FII selling weigh
Indian benchmark indices fell on Wednesday as persistent foreign investor outflows and rising global crude oil prices weighed on market sentiment.
Stock Market Today LIVE: GIFT Nifty signals positive start for Sensex, Nifty
GIFT Nifty signaled a positive start for Sensex and Nifty on Monday, following a strong Friday finish as global oil prices moved lower.
Sensex, Nifty off early highs; ITC rises over 3%, HCLTech worst hit
Indian benchmark indices pared their early-session advances, with ITC leading gains while HCL Technology faced the steepest losses.
Sensex tanks 493 points; Nifty falls sixth day as crude jumps to $91
Indian equity markets faced a sharp sell-off as crude oil prices climbed to $91 a barrel following renewed Middle East conflicts and U.S.-Iran tensions.
Sensex Falls 555 Points as Oil Nears $100 and US Yields Rise
Global equity markets suffered heavy losses as escalating geopolitical tensions pushed Brent crude close to $100 a barrel and US Treasury yields climbed.
Sensex down 320 pts, Nifty below 24,100 as bond yields rise; Brent near $92
Indian equity markets extended their losing streak as the Sensex dropped 319.79 points and the Nifty fell below 24,100 amid rising global bond yields and spiking crude prices.
Indian Stock Markets Open Flat Amid Rising Crude Oil Prices
Indian stock markets are projected to open flat following a sharp decline in the previous session, pressured by rising energy costs and geopolitical tensions.
Crude oil prices plunge more than 9 percent as US pauses strikes on Iran
Crude oil prices plunged more than 9% to $88 a barrel after the US paused strikes on Iran and Tehran signaled restraint, boosting hopes of de-escalation.
Business News Live: Emcure Pharma Q1 net profit rises 42% to Rs 294 crore
Emcure Pharmaceuticals posts a 42% year-on-year increase in net profit for the first quarter, highlighting the latest corporate earnings updates.